Headline News about Global Blood TherVia Benzinga
Exposures
Product Safety
Via Benzinga
Global Blood Therapeutics Q1 Earnings Miss Estimates On Disappointing Sales For Its Sickle-Cell Disease Drug
May 06, 2021
Via Benzinga
Topics
Earnings
Exposures
Financial
Via Benzinga
Exposures
Product Safety
Via Benzinga
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|